Trailing Twelve Months Revenue Growth: Amarin Corporation plc (AMRN)

Graphic logo of Amarin Corporation plc (AMRN)

Amarin Corporation plc is implementing algorithms into the development of cardiology treatments. The business relies critically on external CMOs for drug synthesis and encapsulation, as reflected in this TTM annual sales growth chart, where the figure is recorded at -22.70. The stability of fatty acid supplies is ensured by strict SLA control with chemical partners.

AMRN - amarincorp.com Sales Growth YoY (Last Twelve Months) over the range 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for Amarin (AMRN)

- current quotes and average value forecast:
- company stock exchange capitalization indicators:
Summary company analytics:AMRN (Amarin Corporation plc)
Manufactured product of amarincorp.com

Diversifying the production of cardiovascular drugs in Europe strengthens the supply chain resilience of Amarin Corporation plc (AMRN), which directly impacts the stability of incoming cash flows. The annual growth dynamics of sales volumes over the trailing four quarters measure the percentage change in TTM revenue, neutralizing seasonal fluctuations and allowing investors to assess the real trend of the company's market share expansion through the lens of fundamental analysis.